171 related articles for article (PubMed ID: 23879635)
1. ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells.
Ghosh M; Ryan RO
Nanomedicine (Lond); 2014 May; 9(6):763-71. PubMed ID: 23879635
[TBL] [Abstract][Full Text] [Related]
2. Curcumin nanodisks: formulation and characterization.
Ghosh M; Singh AT; Xu W; Sulchek T; Gordon LI; Ryan RO
Nanomedicine; 2011 Apr; 7(2):162-7. PubMed ID: 20817125
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic Delivery from a Self-Assembling Peptide Nanofiber Hydrogel for the Management of Glioblastoma.
Karavasili C; Panteris E; Vizirianakis IS; Koutsopoulos S; Fatouros DG
Pharm Res; 2018 Jun; 35(8):166. PubMed ID: 29943122
[TBL] [Abstract][Full Text] [Related]
4. Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice.
Qin H; Jiang Y; Zhang J; Deng C; Zhong Z
Mol Pharm; 2019 Aug; 16(8):3711-3719. PubMed ID: 31299161
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Maiti P; Plemmons A; Dunbar GL
PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
[TBL] [Abstract][Full Text] [Related]
6. Curcumin nanodisk-induced apoptosis in mantle cell lymphoma.
Singh AT; Ghosh M; Forte TM; Ryan RO; Gordon LI
Leuk Lymphoma; 2011 Aug; 52(8):1537-43. PubMed ID: 21699455
[TBL] [Abstract][Full Text] [Related]
7. Effects of Photosensitization of Curcumin in Human Glioblastoma Multiforme Cells.
Kielbik A; Wawryka P; Przystupski D; Rossowska J; Szewczyk A; Saczko J; Kulbacka J; Chwiłkowska A
In Vivo; 2019; 33(6):1857-1864. PubMed ID: 31662513
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
9. Recombinant receptor-binding domain of diphtheria toxin increases the potency of curcumin by enhancing cellular uptake.
Kumar A; Das G; Bose B
Mol Pharm; 2014 Jan; 11(1):208-17. PubMed ID: 24224661
[TBL] [Abstract][Full Text] [Related]
10. Novel Nanoscale Delivery Particles Encapsulated with Anticancer Drugs, All-trans Retinoic Acid or Curcumin, Enhance Apoptosis in Lymphoma Cells Predominantly Expressing CD20 Antigen.
Stauffer RG; Mohammad M; Singh AT
Anticancer Res; 2015 Dec; 35(12):6425-9. PubMed ID: 26637852
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a
Zhang M; Lu L; Ying M; Ruan H; Wang X; Wang H; Chai Z; Wang S; Zhan C; Pan J; Lu W
Mol Pharm; 2018 Jun; 15(6):2437-2447. PubMed ID: 29734808
[TBL] [Abstract][Full Text] [Related]
12. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Kundu P; Mohanty C; Sahoo SK
Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
14. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-induced cell death depends on the level of autophagic flux in A172 and U87MG human glioblastoma cells.
Lee JE; Yoon SS; Lee JW; Moon EY
Chin J Nat Med; 2020 Feb; 18(2):114-122. PubMed ID: 32172947
[TBL] [Abstract][Full Text] [Related]
17. Linolenic acid-modified PEG-PCL micelles for curcumin delivery.
Song Z; Zhu W; Liu N; Yang F; Feng R
Int J Pharm; 2014 Aug; 471(1-2):312-21. PubMed ID: 24939613
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway.
Yin S; Du W; Wang F; Han B; Cui Y; Yang D; Chen H; Liu D; Liu X; Zhai X; Jiang C
Cancer Biol Ther; 2018 Apr; 19(4):260-270. PubMed ID: 27819521
[TBL] [Abstract][Full Text] [Related]
19. Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib.
Bagherian A; Roudi B; Masoudian N; Mirzaei H
Food Funct; 2021 Nov; 12(21):10926-10937. PubMed ID: 34647945
[TBL] [Abstract][Full Text] [Related]
20. Solid Lipid Curcumin Particles Induce More DNA Fragmentation and Cell Death in Cultured Human Glioblastoma Cells than Does Natural Curcumin.
Maiti P; Al-Gharaibeh A; Kolli N; Dunbar GL
Oxid Med Cell Longev; 2017; 2017():9656719. PubMed ID: 29359011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
